Skip to Content

CAR T cell therapy

Dr. John Timmerman and Dr. Sarah Larson answer questions about CAR T cell therapy

By Denise Heady • September 23, 2020
https://youtu.be/aqwBBnBspwk

In the late 1960s, a group of scientists and volunteers at UCLA came together to develop a cancer center they hoped would become renowned for excellence in research, education and patient care. Today, UCLA Health’s Jonsson [...]

By uclahealth • November 13, 2019

Researchers have developed a breakthrough in cancer treatment known as chimeric antigen receptor (CAR) T-cell therapy. This promising form of immunotherapy attacks cancerous cells in the body. In 2017, the U.S. Food and Drug Administration (FDA) approved the first CAR T-cell treatments for patients with specific types of leukemia and lymphoma.

What is CAR T-cell therapy?

Immunotherapy [...]

By uclahealth • October 7, 2019

Medical researchers have had breakthroughs in treating certain types of cancer by bolstering a patient’s immune system. Known as immunotherapy, or biologic therapy, it treats cancer differently than established treatments such as chemotherapy, radiation, bone marrow transplant and surgery.

To date, the U.S. Food and [...]

By uclahealth • February 11, 2019